XRTX - XORTX Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-10)
Last
 0.42		 Change
 ⇓ -0.01   (0.00%)		 Volume
  531,746
Open
 0.41		 High
 0.45		 Low
 0.40
8EMA (Daily)
 0.45		 40EMA (Daily)
 0.54		 50EMA (Daily)
 0.56		 STO (Daily)
 15.286		 MACD Hist (Daily)
 -0.009
8EMA (Weekly)
 0.507		 40EMA (Weekly)
 0.74		 50EMA (Weekly)
 0.81		 STO (Weekly)
 11.463		 MACD Hist (Weekly)
 -0.010
Company Profile
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com